Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HBV immunity preservation and donor transfer after non-myeloablative allogeneic HSCT in adult sickle cell disease
NL-OMON23265Not yet recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Jul 2021
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label trial of Hepatitis B vaccine in hepatitis B (HBV) (4 arms), sponsored by Amsterdam University Medical Center. Planned start Jul 2021; status: not yet recruiting.
02
Drugs
Hepatitis B vaccine
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on NL-OMON23265.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON23265.